impact factor
logo
 

Clinical aspects

 

Compromised ultrasound remission, functional ability and clinical decision associated with overlapping Sjögren's syndrome in rheumatoid arthritis patients: results from a propensity-score matched cohort from 2009 to 2019


1, 2, 3, 4

 

  1. Rheumatology and Clinical Immunology Department, Peking University First Hospital, Beijing, China.
  2. Rheumatology and Clinical Immunology Department, Peking University First Hospital, Beijing, China.
  3. Rheumatology and Clinical Immunology Department, Peking University First Hospital, Beijing, China.
  4. Rheumatology and Clinical Immunology Department, Peking University First Hospital, Beijing, China. zhuoli.zhang@126.com

CER13638
2020 Vol.38, N°4 ,Suppl.126
PI 0073, PF 0077
Clinical aspects

Free to view
(click on article PDF icon to read the article)

PMID: 33025891 [PubMed]

Received: 01/06/2020
Accepted : 27/07/2020
In Press: 23/09/2020
Published: 22/10/2020

Abstract

OBJECTIVES:
Rheumatoid arthritis (RA) patients with Sjögren’s syndrome (SS) often present with more severe synovitis. We intended to clarify the impact of overlapping SS on ultrasound remission, functional ability and clinical decision-making in RA patients in a real-world cohort from 2009 to 2019.
METHODS:
The medical records of RA patients in our medical centre from 2009 to 2019 were reviewed. Cox proportional hazards models of ultrasound remission and no disability (by health assessment questionnaire [HAQ]) were conducted in both the 1-to-1 nearest propensity score matched (PSM) and unmatched cohorts between RA patients with SS (RA-SS) and without (RA-noSS) to correct critical confounders. Four kinds of PSM methods were used and the corresponding average treatment effect on the treated (ATT) was calculated to clarify the effect of overlapping SS on distinguishable characteristics or drug prescription in RA patients.
RESULTS:
A total of 1100 RA patients were included in the study, of which 133 (12.1%) overlapped with SS. Among 256 patients consisting of 128 RA-SS and 128 RA-noSS after 1-to-1 nearest PSM, overlapping SS was associated with a 44%, 32% lower probability of reaching ultrasound remission, no disability in RA patients, respectively. More hydroxychloroquine (HCQ) usage, less biologic disease-modifying anti-rheumatic drugs (bDMARDs) prescription were confirmed to be correlated with overlapping SS by the robust PSM.
CONCLUSIONS:
Overlapping SS is associated with a lower probability of reaching ultrasound remission and no disability in RA patients. HCQ may still be the mainstream of clinical decision making in RA-SS patients.

Rheumatology Article